Vayarin Completed Phase 3 Trials for ADHD Inattention or Mixed Type / Children / Attention Deficit Hyperactivity Disorder (ADHD) / Epilepsy / ADHD - Inattentive Type / Attention Deficit Hyperactivity Disorder Combined Treatment

Indications	Status	Purpose	Phase
DBCOND0074063 (ADHD Inattention or Mixed Type) DBCOND0032515 (Children) DBCOND0041782 (Attention Deficit Hyperactivity Disorder (ADHD)) DBCOND0017557 (Epilepsy) DBCOND0060357 (ADHD - Inattentive Type) DBCOND0129171 (Attention Deficit Hyperactivity Disorder Combined)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT02348073	Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy	Vayarin (DB09328)